← All organizations

Arbutus Biopharma Corporation

For profitWebsite ↗

Also known as: Arbutus Biopharma Corporation | Tekmira Pharmaceuticals

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2024

Timeline

1990s

Jun 1, 1992
Arbutus Biopharma Corporation— Founded

Drugs by trial phase (12 distinct, 12 trials)

Phase 2 (6 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT06245291Lead sponsorPhase 2May 1, 2024
NCT06154278CollaboratorPhase 2Dec 1, 2023
NCT05960240Lead sponsorPhase 1Sep 30, 2023
NCT04980482Lead sponsorPhase 2Oct 29, 2021
NCT04820686CollaboratorPhase 2May 7, 2021
NCT04775797Lead sponsorPhase 1Mar 25, 2021
NCT02631096Lead sponsorPhase 2Dec 1, 2015
NCT02631096Study chairPhase 2Dec 1, 2015
NCT02191878Study directorPhase 1/Phase 2Jun 1, 2014
NCT02191878Lead sponsorPhase 1/Phase 2Jun 1, 2014
NCT02041715Study directorPhase 1Jan 1, 2014
NCT02041715Lead sponsorPhase 1Jan 1, 2014
NCT01518881Lead sponsorPhase 1Jan 1, 2012
NCT01262235Lead sponsorPhase 1/Phase 2Dec 1, 2010
NCT01262235Study directorPhase 1/Phase 2Dec 1, 2010

Details

Founded: Burnaby, BC, CA Jun 1, 1992
Last known activity: May 1, 2024